SCHEMBL25925792

SCHEMBL25925792

Cc1noc(/N=N/c2c(O)ccc(/N=N/c3snc4ccc(S(N)(=O)=O)cc34)c2O)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
CDK1 P06493 3/20 0.32
CDK2 P24941 3/20 0.32
CCNA2 P20248 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
HIF1A Q16665 1/20 0.32
GLO1 Q04760 3/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
CASP6 P55212 1/20 0.31
ATM Q13315 1/20 0.31
KLF5 Q13887 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
PIK3CD O00329 1/20 0.30
MTOR P42345 1/20 0.30
PIK3CG P48736 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925809 0.86 KMT2A (0.35) MEN1KMT2AMAPTCDK1CDK2
SCHEMBL25925819 0.80 MEN1 (0.42) MEN1KMT2AMAPTCDK1CDK2
SCHEMBL25927208 0.80 PTGS2 (0.36) MEN1KMT2AMAPTCDK1CDK2
SCHEMBL25925772 0.80 CYP1A2 (0.36) MEN1KMT2AMAPTCDK1CDK2
SCHEMBL25925802 0.76 MAPT (0.35) MEN1KMT2AMAPTCYP1A2CYP2C9
SCHEMBL25925806 0.75
SCHEMBL25925804 0.74
SCHEMBL25925798 0.73
SCHEMBL25925921 0.73 GLO1 (0.41) MEN1KMT2AMAPTCDK1CDK2
SCHEMBL25925762 0.71 MAPT (0.31) MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 MEN1 67/4885KMT2A 1814/4885MAPT 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.